MAN2B2
Epididymis-specific alpha-mannosidase
Also known as: EpMAN, KIAA0935, MA2B2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2E5
- Gene
- MAN2B2
- Ensembl
- ENSG00000013288
- Chromosome
- 4
- Canonical length
- 1009 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Predicted to enable alpha-mannosidase activity. Predicted to be involved in mannose metabolic process and oligosaccharide catabolic process. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1009 residues, UniProt reviewed canonical sequence.
>Q9Y2E5|MAN2B2
1 MGQLCWLPLL APLLLLRPPG VQSAGPIRAF VVPHSHMDVG WVYTVQESMR AYAANVYTSV
61 VEELARGQQR RFIAVEQEFF RLWWDGVASD QQKYQVRQLL EEGRLEFVIG GQVMHDEAVT
121 HLDDQILQLT EGHGFLYETF GIRPQFSWHV DPFGASATTP TLFALAGFNA HLGSRIDYDL
181 KAAMQEARGL QFVWRGSPSL SERQEIFTHI MDQYSYCTPS HIPFSNRSGF YWNGVAVFPK
241 PPQDGVYPNM SEPVTPANIN LYAEALVANV KQRAAWFRTP HVLWPWGCDK QFFNASVQFA
301 NMDPLLDHIN SHAAELGVSV QYATLGDYFR ALHALNVTWR VRDHHDFLPY STEPFQAWTG
361 FYTSRSSLKG LARRASALLY AGESMFTRYL WPAPRGHLDP TWALQQLQQL RWAVSEVQHH
421 DAITGTESPK VRDMYATHLA SGMLGMRKLM ASIVLDELQP QAPMAASSDA GPAGHFASVY
481 NPLAWTVTTI VTLTVGFPGV RVTDEAGHPV PSQIQNSTET PSAYDLLILT TIPGLSYRHY
541 NIRPTAGAQE GTQEPAATVA STLQFGRRLR RRTSHAGRYL VPVANDCYIV LLDQDTNLMH
601 SIWERQSNRT VRVTQEFLEY HVNGDVKQGP ISDNYLFTPG KAAVPAWEAV EMEIVAGQLV
661 TEIRQYFYRN MTAQNYTYAI RSRLTHVPQG HDGELLCHRI EQEYQAGPLE LNREAVLRTS
721 TNLNSQQVIY SDNNGYQMQR RPYVSYVNNS IARNYYPMVQ SAFMEDGKSR LVLLSERAHG
781 ISSQGNGQVE VMLHRRLWNN FDWDLGYNLT LNDTSVVHPV LWLLLGSWSL TTALRQRSAL
841 ALQHRPVVLF GDLAGTAPKL PGPQQQEAVT LPPNLHLQIL SIPGWRYSSN HTEHSQNLRK
901 GHRGEAQADL RRVLLRLYHL YEVGEDPVLS QPVTVNLEAV LQALGSVVAV EERSLTGTWD
961 LSMLHRWSWR TGPGRHRGDT TSPSRPPGGP IITVHPKEIR TFFIHFQQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAN2B2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 49 nTPM
- choroid plexus: 30 nTPM
- ovary: 25 nTPM
- liver: 23 nTPM
- thyroid gland: 22 nTPM
- heart muscle: 22 nTPM
Single-cell type
- endometrial luminal cells: 51 nCPM
- hepatocytes: 49 nCPM
- kupffer cells: 46 nCPM
- salivary duct cells: 40 nCPM
- prostatic glandular cells: 39 nCPM
- conjunctival goblet cells: 36 nCPM
Immune cell
- non-classical monocyte: 18 nTPM
- basophil: 16 nTPM
- eosinophil: 14 nTPM
- intermediate monocyte: 13 nTPM
- gdT-cell: 12 nTPM
- neutrophil: 11 nTPM
Brain region
- choroid plexus: 62 nTPM
- cerebral cortex: 44 nTPM
- hypothalamus: 39 nTPM
- midbrain: 35 nTPM
- medulla oblongata: 34 nTPM
- basal ganglia: 34 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAN2B2.
Disease | AllUniProt
Conditions MAN2B2 is implicated in, by any mechanism.
- Congenital disorder of glycosylation 1EE with or without immunodeficiency (CDG1EE) MIM:621140
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 358 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital disorder of glycosylation type 1EE with or without immunodeficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.26
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- alpha-mannosidase activity
- carbohydrate binding
- metal ion binding
- mannan endo-1,6-alpha-mannosidase activity
- mannosyl-oligosaccharide 1,6-alpha-mannosidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycoside hydrolase family 38, N-terminal domain
- Galactose mutarotase-like domain superfamily
- Glycoside hydrolase/deacetylase, beta/alpha-barrel
- Glycosyl hydrolase family 38, C-terminal
- Glycosyl hydrolase, all-beta
- Glycoside hydrolase family 38, central domain
- Glycoside hydrolase 38, N-terminal domain superfamily
- Glycoside hydrolase families 57/38, central domain superfamily
- Glycoside hydrolase family 38, central domain superfamily
- Glycosyl Hydrolase Family 38
- Glycosyl hydrolases family 38 N-terminal domain
- Glycosyl hydrolases family 38 C-terminal domain
- Alpha mannosidase middle domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAN2B2 as an antibody target. Whether an autoantibody or antibody against MAN2B2 could matter depends on whether native MAN2B2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAN2B2 is annotated as secreted, so native MAN2B2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MAN2B2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...